Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Jr

Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Jr

Obeng EA, Carlson LM, Gutman DM, Harrington WJ, Jr., Lee KP, Boise LH. c-Met, which are degraded on Hsp90 inhibition also. Hsp90 inhibitors may be synergistic with additional medicines that disrupt chaperone function, including inhibitors of histone deacetylase 6 as well as the proteasome and